BioHarvest Sciences Inc.
BioHarvest Sciences Inc.
CSE Index:
Currency:
BioHarvest Sciences produces and sells a food-based Nutraceutical product called ViniaTM which contains the whole range of piceid resveratrol in natural state . The product is made by growing plant cells from red grapes in bioreactors utilizing the Issuer’s platform technology which allows the growing of specific cells instead of the whole plant. The Issuer is also completing research to adapt its platform technology to growing of cannabis cells under a cannabis research license in Israel.
BioHarvest Sciences Inc. (BHSC)
SEDAR Information
Company Info
Address
1140 - 625 Howe St.
Vancouver, BC V6C 2T6
CanadaPhone
604-622-1186Fax
604-685-9182Email
info@bioharvest.comWebsite
http://www.bioharvest.comListing date
Tuesday, August 4, 2015Transfer Agent
National Securities Administrators Ltd.Auditor
BDOCapitalization
Issued & Outstanding:
431,499,251Reserved for Issuance:
93,498,448Company Officers
David Ryan, Vice President of Investor Relations, Secretary & Director
Zaki Rakib, Chairman & Director
Liron Carmel, Director
Vivien Rakib, Director
Yochi Hagay, CTO
Alan Rootenberg, CFO
Jake Fiddick, Director
Ilan Sobel, CEO
News Releases
Bulletins
21/04/2020
2020-0428 – Fundamental Change - Canna-V-Cell Sciences Inc./BioHarvest Sciences Inc.
Le 21 avril/April 2020
BioHarvest Sciences Inc., the issuer resulting from a Fundamental Change of Canna-V-Cell Sciences Inc., has been approved for listing.
Listing and disclosure documents are available at www.thecse.com.
CSE Filings
Advertisement
Publicité
